LUMC-BOB1-B7-TCR.1 clinical trials

BOB1-TCR therapy for treatment of relapsed or refractory B-cell malignancies - A Phase 1/2 clinical trial

This study is looking at a new type of treatment for certain blood cancers like leukaemia and lymphoma. It's called BOB1-TCR therapy. The first part checks if the treatment is safe and what dose to use, and the second part looks at how well it works.